A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma-Reference-Cited by-同舟云学术

A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma

Published:2019-07-30 Issue:9 Volume:39 Page:1704-1712
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Lee I‐Cheng¹²,Hung Ya‐Wen¹,Liu Chien‐An³⁴,Lee Rheun‐Chuan³,Su Chien‐Wei¹²^ORCID,Huo Teh‐Ia¹⁵^ORCID,Li Chung‐Pin¹²,Chao Yee⁶,Lin Han‐Chieh¹²^ORCID,Hou Ming‐Chih¹²,Huang Yi‐Hsiang¹²⁴^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Medicine Taipei Veterans General Hospital Taipei Taiwan

2. Faculty of Medicine National Yang‐Ming University School of Medicine Taipei Taiwan

3. Department of Radiology Taipei Veterans General Hospital Taipei Taiwan

4. Institute of Clinical Medicine National Yang‐Ming University Taipei Taiwan

5. Institute of Pharmacology National Yang‐Ming University School of Medicine Taipei Taiwan

6. Cancer Center Taipei Veterans General Hospital Taipei Taiwan

Funder

Ministry of Science and Technology, Taiwan

Taipei Veterans General Hospital

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14194

Reference32 articles.

1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

2. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

3. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

4. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

5. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current research status of transarterial therapies for hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-09-15

3. Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation;Alimentary Pharmacology & Therapeutics;2024-08-07

4. TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study;Frontiers in Immunology;2024-07-26

5. A novel radiomics approach for predicting TACE outcomes in hepatocellular carcinoma patients using deep learning for multi-organ segmentation;Scientific Reports;2024-06-26